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Abstract
Background: Deficient and insufficient vitamin D status (defined as serum 25(OH)D < 30 nmol/L and > 50 nmol/L)
is prevalent worldwide and associated with decreased muscle strength and poor bone health. We aimed to
investigate the effect of vitamin D fortification on bone markers and muscle strength among younger adult women
at risk of vitamin D deficiency.
Methods: A 12-week randomised double-blinded placebo-controlled winter intervention trial, providing 30 μg
vitamin D3/day through fortified yoghurt, cheese, eggs and crisp-bread or similar placebo products. Participants
were 143 women of Danish and Pakistani origin 18–50 years of age, living in Denmark, randomised into four groups
stratified by ethnicity. Serum 25-hydroxyvitamin D (25(OH)D) by LC-MS/MS and the secondary endpoints: four
specific bone markers (osteocalcin (OC), Bone specific Alkaline Phosphatase (BALP), Procollagen type 1 amino-
terminal propeptide (P1NP), C-terminal crosslinked telopeptide of type 1 collagen (CTX)) and three muscle strength
measures (handgrip, knee extension strength, chair-standing), were assessed using one-way ANOVA, Tukey HSD and
subsequent linear ANCOVA models, adjusted for relevant covariates.
Results: Significantly increased serum 25(OH)D concentration from 53.3 (17) to 77.8 (14) nmol/L and from 44.5 (21)
to 54.7 (18) nmol/L among Danish and Pakistani women in the fortified groups, respectively (P < 0.05). The bone
turnover markers OC, BALP, P1NP and CTX did not change significantly. Muscle strength by handgrip, knee
extension and chair-standing test did not change significantly following the intervention.
Conclusions: Consumption of vitamin D fortified foods for 12 weeks did not result in significant changes of the
bone turnover markers OC, BALP, P1NP and CTX. Muscle strength measured as hand grip strength, knee extension
strength and chair-standing did not change significantly following the intervention.
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Bone regeneration
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Introduction
Vitamin D has a well-established role in the calcium and
phosphorus homeostasis and is essential for bone health
[1, 2]. Studies have shown associations between vitamin
D deficiency and insufficiency, here and throughout this
paper, defined as serum 25(OH)D concentrations < 30
and < 50 nmol/L, respectively [3, 4], and non-skeletal
endpoints such as muscular atrophy, muscle pain and
decreased muscle strength [5–7]. Vitamin D deficiency
and insufficiency is a prevalent worldwide problem [8].
Especially in northerly countries such as Denmark in
which the absence of vitamin D from UVB sources
during winter increases the risk of deficiency and insuffi-
ciency [9, 10]. Immigrants (first generation and descen-
dants) living in Denmark as well as other Nordic
countries are considered at risk of vitamin D deficiency
due to factors such as skin colour, cultural clothing and
dietary habits [11–13].
Bone tissue is a dynamic structure that undergoes
constant remodelling, and optimal bone health is a bal-
ance between bone resorption and bone formation. In a
case of chronic bone resorption, the bone mineral dens-
ity (BMD) will decrease with time [14]. The bone turn-
over can be monitored by bone biomarkers in the
blood, and is therefore a potential cost-effective method
to complement BMD measurements in situations where
BMD is not a feasible endpoint e.g. studies of shorter
duration [14, 15].
Recent advances have located vitamin D receptors
(VDR) within muscle tissue, supporting the assumption
that vitamin D has an effect on muscle function [16, 17].
Some intervention studies have found an effect of
vitamin D on muscle strength [18, 19] and some effect
in the number of falls [20], while other studies were un-
able to see an effect [21]. These inconsistent trends may
be related to the baseline serum 25(OH)D concentration
and the effect of vitamin D supplementation is more
pronounced on vitamin D deficient people (25(OH)D
concentrations < 25–30 nmol/L) [18, 19]. Additionally,
assessment of the effect of vitamin D on muscle strength
has primarily been studied among elderly subjects
(mainly community dwelling), and there is a lack of data
on the effects of vitamin D on muscle strength in young
adults deficient in vitamin D [22]. The mechanism of
vitamin D and muscle function has not been agreed
upon, however, it has been hypothesised that the active
metabolite of vitamin D (1,25(OH)2D) vitamin D is
involved in the regulation of the calcium flow within the
muscle through genomic and non-genomic pathways
and is thus important for the contraction of muscle
fibres [5, 17].
We aimed to investigate the effect of 12 weeks of inter-
vention with vitamin D fortified foods on markers of
bone turnover and muscle strength in a population of
women of Danish and Pakistani origin between 18 and
50 years of age, at risk of vitamin D deficiency. Our
hypothesis was that 12 weeks of intervention with 30 μg
vitamin D3/day would significantly improve muscle
strength in a population of Danish and Pakistani women
at risk of vitamin D deficiency.
Methods
Study design
This paper is based on intervention data from a food-
based randomised controlled trial (RCT) ODIN-FOOD.
The intervention was designed to assess the change in
serum 25-hydroxyvitamin D3 as the primary endpoint
following fortification, while measurements of muscle
strength and bone turnover markers were secondary
outcomes. The main study outcomes of the ODIN
FOOD project have been included in a previous publica-
tion [23], we will refer to this publication throughout the
methods for further details.
The present study was a three month double-blinded
RCT. A total of 143 women of Danish (n = 71) and
Pakistani (n = 72) origin between 18 and 50 years at risk
of vitamin D deficiency were enrolled in the study (see
Table 1). Details of the study design, recruitment (flow
diagram), randomisation and blinding has been de-
scribed previously [23]. The subjects were given four
different vitamin D fortified foods contributing with
30 μg/day (intervention group) or non-fortified foods
(placebo group). The intervention was performed during
the winter months (Jan. - Apr.) to minimise interference
from cutaneous produced vitamin D. Participants were
seen before the intervention start (January 2016) and at
the end of intervention after 3 months (April 2016). At
the visits blood was drawn, anthropometrics, dietary
vitamin D intake and muscle strength were measured.
The assessed endpoints were hand grip strength, knee
extension strength, number of chair-stands in a 30-s
chair stand test, and concentrations of four different
bone turnover markers (OC, BALP, P1NP, CTX).
Sample size was based on 90% power (alpha = 5%) to
detect a change in 25(OH)D concentration of 20 nmol/L
in the treatment group with a standard deviation (SD) of
23, and a drop-out rate of 20%.
Participants
The participants were of Danish and Pakistani origin,
recruited from the Copenhagen area, city and suburbs
(Denmark, 55°N). The recruitment was carried out in
the autumn of 2016 by e-mail, advertisements and
networking, as described elsewhere [23]. Inclusion cri-
teria were a low consumption of fish and fish products
(less than weekly), a low intake of vitamin D-containing
supplements (less than weekly), no use of tanning facil-
ities, no planned sun-holiday (more southerly than 47°N)
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between October 2015 and May 2016. No upper limit of
the concentration of vitamin D in the supplement was
specified as long as the participants stopped taking them
at the time of enrolment in the study. Exclusion criteria
were pregnancy and breastfeeding, menopause, non-
Danish speakers, serious diseases (cancer, server liver or
kidney insufficiencies, sarcoidosis and other granuloma-
tous diseases) and medicines affecting the vitamin D me-
tabolism (steroids, antiepileptic, thyroid hormones,
bisphosphonates, oestrogen).
Study foods
The intervention foods were low-fat Milner cheese
(gouda) and yoghurt (plain) produced and provided free
of cost by FrieslandCampina in the Netherlands, eggs
(Livskraft) produced and provided free of cost by Hede-
gaard in Denmark, and whole wheat biscuits produced
by Smørum konditori (confectionary) with ingredients
supplied free of cost by Lantmännen Cerealia, Denmark,
with vitamin D3 supplied by DSM nutritional products,
Switzerland. The study foods were either placebo or for-
tified with vitamin D3 with the aim of increasing the
total vitamin D status in an effective and safe manner in
both ethnic groups. Foods highly representative and ac-
ceptable in both traditional Danish and Pakistani kitchen
were chosen. The daily portion sizes were 150 g yoghurt,
60 g cheese, 1 egg and 1 small crisp bread (9 g). The for-
tified and non-fortified foods have the same fat percent-
age and comparable content of nutrients, except for the
content of vitamin D3.
Random samples from every batch were analysed for
vitamin D content at the National Food Institute in
Denmark and the total daily vitamin D content was
29 μg/day (further details on vitamin D content, metabo-
lites and methods described elsewhere, [23]).
Measurements
Blood procurement procedures
At each of the two study visits non-fasting blood sam-
ples were obtained between 9 am and 16 PM for the ma-
jority of the samples. Efforts were made to book the
endpoint measurement at the same time as baseline visit
for each participant.
Anthropometric measures and questionnaires
Anthropometric measures were height (cm) (wall
mounted stadiometer, seca, Hamburg, Germany), weight
(kg), waist-hip circumference (cm) (standard tape meas-
ure) and body composition (Tanita BC 418 MA, Tokyo,
Japan), as described elsewhere [23]. At baseline the par-
ticipants completed two questionnaires, a general back-
ground questionnaire containing questions regarding
general health, physical activity (during work and leisure
time, if the participants had a job) and lifestyle, and a
semi-quantitative Food Frequency Questionnaire (FFQ)
estimating the average daily intake of vitamin D and cal-
cium. The FFQ was a retrospective questionnaire asking
about the participants’ habitual dietary intake of vitamin
D-rich foods over the 3 preceding months. The ques-
tionnaire contained the 8 food groups (fish, meat, milk
and milk products, egg, cheese, bread, fats and pulses)
Table 1 Baseline characteristics of participants by study group and ethnicity1
Danish Pakistani
Total (n = 66) Placebo (n = 35) Fortified (n = 31) Total (n = 70) Placebo (n = 37) Fortified (n = 33)
Born in Denmark (%) 99 100 99 62 70 54
Years lived in Denmark2 – – – 20 21 18
Mean age in years (SD) 33 (11) 34 (11) 32 (11) 36 (9) 36 (9) 36 (10)
Age range (years) 18–50 18–50 18–50 18–50 18–50 18–47
Mean weight in kg (SD) 68 (13) 70 (15) 67 (11) 70 (12) 68 (13) 70 (12)
BMI (kg/m2)* 24 (5) 25 (5) 24 (4) 27 (5) 27 (5) 27 (5)
Mean serum 25(OH)D (nmol/L) 49.6 (18) 46.2 (19) 53.3 (17) 46.9 (22) 49.0 (23) 44.5 (21)
Mean plasma creatinine (μmol/l) 61.4 (10) 61.4 (9) 61.4 (10) 58.0 (9) 57.8 (10) 58.0 (8)
Median dietary vitamin D intake (μg/d)* 1.5 (1.0; 2.0) 1.5 (1.0; 2.0) 1.7 (1.0; 2.1) 1.1 (1.0; 2.0) 1.1 (0.8; 1.4) 1.0 (0.7; 1.7)
Median dietary calcium intake (mg/d) 465 (324; 688) 487 (309; 685) 442 (331; 692) 441 (260; 589) 422 (262; 547) 465 (259; 634)
Smokers (%) 14 14 13 4 3 6
Alcohol drinkers (%)¶ 86 89 84 1.4 3 0
Wearing hijab (%)¶ 0 0 0 44 43 45
1Means and SD unless otherwise specified. If non-normally distributed, medians and 25th and 75th percentiles.
2Years lived in Denmark on average, if not born in Denmark.
*Significant difference between Danish (all) and Pakistani (all) women in an unpaired t test (P < 0.05).
¶Significant difference between Danish (all) and Pakistani (all) women in a Pearson’s chi2 test.
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contributing to the majority of dietary vitamin D (98%)
and calcium (71%) found in a general diet [24]. The
weekly compliance was monitored by a self-reported
user-friendly compliance questionnaire as described in
details elsewhere [23].
Markers of bone turnover
In this paper we used the bone markers OC, BALP
and P1NP for the assessment of the bone formation
and CTX as a marker of bone resorption, based on
previous studies carried out in a similar population
group [25, 26].
The biochemical analyses of the bone turnover
markers OC, BALP, P1NP, and CTX were performed at
the University Hospital Aarhus. OC had a precision of ±
0.55 μg/L (SD) at a concentration of 19 μg/L and ±
2.75 μg/L (SD) at a concentration of 92 μg/L. BALP had
a precision of ±0.45 μg/L (SD) at a concentration of
4.5 μg/L and ± 4.6 μg/L (SD) at a concentration of
45.9 μg/L. P1NP had a precision of ±1.1 μg/L (SD) at a
concentration of 30 μg/L and ± 7.6 μg/L (SD) at a con-
centration of 205 μg/L. CTX had a precision of ±
0.015 μg/L (SD) at a concentration of 0.26 μg/L and ±
0.03 μg/L (SD) at a concentration of 0.59 μg/L.
Muscle function
Both upper and lower limb muscle function were mea-
sured using different physical tests. Upper limb muscle
strength was measured as isometric hand grip strength
(measured in kg) using a digital hand dynamometer
(SAEHAN Corporation, South Korea) which have previ-
ously been demonstrated to have high inter-rate and
test-retest reliability [27]. Participants were seated on a
chair with the arm in a 90° elbow flexion, and the fore-
arm in mid-prone neutral position. The handle of the
dynamometer was placed in position 2, thereby fitting
the standard hand size for adults. All participants had
two familiarisation trials prior to the maximal contrac-
tion test. A minimum of three maximal isometric con-
tractions were conducted with the dominant hand with
a 90-s break between each measurement. If the last con-
traction was the highest, the participants had up to two
additional contractions. The instructor gently supported
below the instrument to minimised an effect of gravity.
Muscle strength was calculated as the mean of the three
highest values obtained (averaged peak grip strength).
The intra-assay coefficient of variation (CV) for hand
grip strength was 4.0%.
Lower limb muscle strength was measured as isomet-
ric knee extension strength (measured in kg) using a
digital handheld muscle tester (MicroFET2, Hoggan
Scientific, USA). The MicroFET2 dynamometer was
belt-stabilised to the table, so that the instructor would
only have to concentrate on holding the dynamometer
in the correct position on the ankle [28].The participants
were seated on a table fitted with a non-skid material in
an upright position with a 90° hip flexion and arms
placed on the lap. The lower leg was hanging down
about 1 cm from the edge of the table without touching
the floor. The MicroFET2 dynamometer was placed on
the front of the ankle, on the dominant leg, approxi-
mately 4 cm above the lateral malleoli. The participants
were asked to stretch their leg as much as they could
for approximately 5 s. The participants had two famil-
iarisation trials where they were asked to stretch their
leg using ≈ half of maximal power. This was followed
by 3–5 maximal contractions lasting approximately 5 s
with a 90-s break between each measurement. Muscle
strength was calculated as the mean of the three
highest values obtained. The intra-assay CV for knee
extension strength was 4.2%.
Lower limb muscle function was also measured by a
30-s chair-stand test, as a measurement of anaerobic
muscle function. Participants were seated on a chair (43
cm high, without arm rest). Arms were folded across the
chest, and the number of full stands achieved in 30 s
were recorded [29].
25(OH)D-measurements and other biochemical
measurements
Serum concentrations of total 25(OH)D (i.e., 25(OH)D2
plus 25(OH)D3) of all serum samples (baseline and
endpoint visits) were measured at the Cork Centre for
Vitamin D and Nutrition Research, University College
Cork (UCC), using the ODIN core LC-MS/MS analytical
platform for serum 25(OH)D, described in detail else-
where [30]. The intra-assay CV of the method was < 5%
for all 25(OH)D metabolites, whilst the inter-assay CV
was < 6%. The LC-MS/MS method at UCC is certified
by the Centre for Disease Control and Prevention’s Vita-
min D Standardization Certification Program (VDSP).
Serum creatinine a marker of muscle mass [31] was
measured at the University Hospital Aarhus. Creatinine
had the following precisions at specific concentrations:
At 81 μmol/L ± 7.4% (95% CI) and at 567.0 μmol/L ±
5.0% (95% CI) and biological variation of ±11.9% (95%
CI).
Statistical analysis
Results are shown as means (SD) unless otherwise speci-
fied. Descriptive statistics were calculated using a two-
sample t test or the non-parametric Kruskal Wallis test
for comparing the two ethnic groups. Categorical vari-
ables were compared using a Pearson’s chi-square test.
Simple one-way ANOVA were used to test for signifi-
cant baseline comparison across the four study groups
(DK placebo, DK fortified, PA placebo, Pa fortified) and
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a subsequent Tukey HSD test showed which groups
were responsible for the difference.
ANCOVA analysis of covariance was used to analyse
the effect of the intervention on the respective outcome
variables (muscle strength and markers of bone turn-
over). We adjusted for age, ethnicity, BMI and study
group as well as the respective baseline variables. Finally,
to check the model assumptions the standardized resid-
uals of the models were assessed visually for normality,
variance homogeneity and linearity. Compliance was es-
timated individually by dividing the individual amount
of food with the individual self-reported compliance the
final compliance is shown as the percentage consumed
foods of delivered foods.
Statistical analyses were performed using RStudio for
Windows [32] (Version 1.1.414 –© 2009–2018 Rstudio,
Inc.) with a significance level of α = 0.05.
Results
Subject characteristics
Baseline characteristics relating to anthropometrics, diet-
ary intake of vitamin D and calcium, vitamin D status
are listed in Table 1, a flow diagram has previously been
published [23]. The mean baseline vitamin D status
among the women of Danish and Pakistani origin were
49.6 (18) and 46.9 (22) nmol/L, respectively (no ethnic
difference P = 0.8). At baseline 9 and 24% of the partici-
pants of Danish and Pakistani origin, respectively, had a
vitamin D status below 30 nmol/L (distribution data
shown elsewhere [23]). The women of Pakistani origin
had a slightly higher BMI and fat percentage compared
to the women of Danish origin (t test, both P < 0.001,
data not shown) and lower lean mass (t test, P < 0.001,
data not shown).
Baseline self-reported physical activity and health are
listed in Table 2. Among the participants of Danish ori-
gin 24% reported their health as “very good”, this was
only the case with 7% among the participants of Paki-
stani origin. Accordingly, 33% the women of Pakistani
origin reported “somewhat bad”, whereas only 4% of the
women of Danish origin reported this. When asked to
compare the overall health with others of the same age,
6 and 26% of the women of Danish and Pakistani origin,
respectively, reported “worse”.
Intervention effects on bone markers and muscle
strength
Generally, the differences seen at baseline were also ob-
served at endpoint. We saw no significant change in
bone turnover markers following the intervention, un-
adjusted ANOVA (P > 0.05, Table 3). We saw no signifi-
cant differences in the changes in muscle strength
(Table 4), despite that the intervention was effective in
increasing the mean serum 25(OH)D concentration
from 53.3 (17) to 77.8 (14) nmol/L and from 44.5 (21) to
54.7 (18) nmol/L among the fortified Danish and Paki-
stani women, respectively (P < 0.05) (data shown in full
in previous publication [23]).
Linear models
The intervention with vitamin D fortified foods showed
no effect on the markers of bone turnover OC, CTX,
BALP and P1NP, analysed in an ANCOVA including the
baseline covariates age, ethnicity, intervention group and
BMI. Only the baseline concentration of each marker of
bone turnover had a significant influence on the end-
point concentration of the specific bone marker
(Table 5).
Considering the muscle strength tests, fortification
with vitamin D did not have a significant effect on the
muscle strength measured as hand grip strength, only
the baseline hand grip strength had a significant influ-
ence on the endpoint hand grip strength (Table 6).




Physical activity score, no job1, n (%) n total DK = 3 n total Pa = 22
1: Sedentary 0 (0%) 3 (14%)
2: Light 1 (33%) 15 (68%)
3: Medium 2 (67%) 3 (14%)
4: Heavy 0 (0%) 1 (4%)
Physical activity score, job and
leisure, n (%)
n total DK = 63 n total Pa = 48
1: Sedentary 5 (8%) 10 (21%)
2: Light 31 (49%) 28 (58%)
3: Medium 22 (35%) 9 (19%)
4: Heavy 5 (8%) 1 (2%)
Self-rated health, n (%) n total DK = 66 n total Pa = 70
1: Very good 24 (36%) 5 (7%)
2: Somewhat good 37 (56%) 34 (49%)
3: Somewhat bad 4 (6%) 23 (33%)
4: Very bad 1 (2%) 8 (11%)
Self-rated health compared to
others of same age, n (%)
n total DK = 66 n total Pa = 70
1: A lot better 6 (9%) 4 (6%)
2: Somewhat better 16 (24%) 21 (30%)
3: The same 40 (61%) 27 (38%)
4: Worse 4 (6%) 18 (26%)
1Participant divided according to job situation in order to determine physical
activity during their daily activities. Participant with a job were asked about
activity during work and leisure time, participants without a job were asked
about activities throughout the day, the only difference were the formulation
of the questions. Physical activity score is a mean of eight self-rated questions
on physical activity and sedentary time. The questions on physical activity is
adapted from a previous intervention study [33]
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Discussion
Following the 12-week intervention with vitamin D forti-
fication no significant changes in the concentration of
the markers of bone turnover OC, BALP, P1NP and
CTX. Additionally, no significant increase in muscle
strength in the two fortified groups and no significant
decrease in muscle strength of the placebo groups were
measured.
We expected a low baseline vitamin D status among
our study population (< 30 nmol/L) as a previous Danish
study from 2008, also including women of Pakistani ori-
gin found a very low baseline vitamin D status (< 15
nmol/L) [11, 25], and because a recent Danish study
found a large proportion of participants (n = 2565) with
a serum 25(OH)D status below 50 nmol/L in at least one
of the seasons [34], suggesting that insufficiency is
prevalent. In order to recruit only women at risk of vita-
min D deficiency in the present study, we used restrict-
ive inclusion criteria allowing only women with a low
intake of fish and supplements as well as a low UVB ex-
posure to be enrolled in the study (described elsewhere
in detail, [23]). Despite vitamin D exposure-specific in-
clusion criteria, the mean baseline vitamin D status of
the participants in this trial were 49.6 (18) and 46.9 (22)
nmol/L in participants of Danish and Pakistani origin,
respectively. We saw that 9% of the participants of Da-
nish origin and 24% of participants of Pakistani origin
had a serum 25(OH)D concentration below 30 nmol/L
at baseline (data shown in full length elsewhere [23]). In
the previously mentioned study from 2008 by Andersen
et al. the distribution of extremely deficient and deficient
vitamin D status among the women of Pakistani origin
were reported as serum 25(OH)D concentration ≤ 10
or > 10- ≤ 25 nmol/L, and the prevalence was 40 and
44%, respectively at baseline [11, 25]. This may indicate
that the vitamin D status among women of Pakistani ori-
gin living in Denmark have improved during the last 10
years, although it is important to be aware of the present
study may be affected by social selection bias as is the
case with any other health- or nutrition-related interven-
tion study.
Observational studies report increased bone resorption
with vitamin D deficiency [35, 36]. Despite observations
of increased bone turnover, RCT’s assessing the effect of
vitamin D supplementation on markers of bone turnover
have shown inconsistent results [25, 26, 37–39].
Our study differs from these previous RCT’s by includ-
ing both women of Pakistani origin and Danish origin
and we used four different vitamin D fortified foods in-
stead of a vitamin D supplements. The relatively high
baseline serum 25(OH)D concentration seen among the
women of Danish and Pakistani origin of 49.6 (18) and
46.9 (22) nmol/L, respectively, may be a reason for not
finding an effect of vitamin D supplementation on
Table 3 Markers of bone turnover: OC, CTX, BALP, P1NP at baseline, endpoint and the change following intervention1
Danish Pakistani
Placebo (n = 35) Fortified (n = 31) Placebo (n = 37) Fortified (n = 33) P2
OC (μg/L)
Baseline 23.9 (9.6)d 25.2 (8.7)bc 19.6 (8.4)c 18.2 (5.6)bd 0.001
Endpoint 22.3 (9.0) 22.7 (6.8)b 19.5 (8.9) 17.4 (5.0)b 0.03
Change −1.2 (4.2) −2.3 (4.6) −0.20 (4.0) −0.5 (2.9) 0.19
CTX (ng/mL)
Baseline 0.25 (0.14) 0.30 (0.15) 0.27 (0.19) 0.21 (0.1) 0.13
Endpoint 0.23 (0.14) 0.26 (0.12) 0.24 (0.16) 0.19 (0.1) 0.20
Change −0.006 (0.1) − 0.05 (0.1) − 0.03 (0.1) − 0.02 (0.1) 0.38
BALP (μg/L)
Baseline 15.5 (7.0) 16.6 (5.2) 15.9 (5.2) 16.9 (7.9) 0.79
Endpoint 13.4 (5.4) 14.0 (4.4) 14.6 (4.9) 14.6 (6.0) 0.74
Change −1.5 (3.5) −1.5 (3.6) − 1.4 (2.1) − 1.8 (4.5) 0.97
P1NP (μg/L)
Baseline 50.7 (25.2) 54.6 (19.6) 46.6 (19.6) 48.1 (17.2) 0.42
Endpoint 46.4 (23.8) 51.1 (16.8) 48.5 (21.0) 45.7 (14.7) 0.72
Change −2.0 (7.9) −2.6 (11.0) 1.7 (10.3) −1.7 (10.4) 0.31
1Means and SD unless otherwise specified.
2P values for comparisons over the four study groups were determined with the use of a one-way ANOVA followed by Tukey’s HSD test. Significant comparisons
a: DK Placebo vs DK Fortified, b: PA Fortified vs DK Fortified, c: PA Placebo vs DK Fortified, d: PA Fortified vs DK Placebo, e: PA Placebo vs DK Placebo, f: PA
Placebo vs PA Fortified.
OC Osteocalcin, BALP Bone specific Alkaline Phosphatase, P1NP Procollagen type 1 amino-terminal propeptide, CTX C-terminal crosslinked telopeptide of type
1 collagen
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markers of bone turnover. When vitamin D status is
above the suggested cut off optimal concentration (> 50
nmol/L), PTH concentration will be within the normal
range and calcium will not be released from the bone
matrix to support the calcium balance [36].
Observational data have shown correlations between
vitamin D status and muscle strength [40], however,
when studied in RCT’s the effects of vitamin D appear
inconclusive [41]. The majority of the published studies
have been performed in older adults (> 50 years). Two
larger systematic review and meta-analyses including 17
and 30 RCT’s, respectively, found that the effect of vita-
min D supplementation may only be present among
vitamin D deficient people (Vitamin D concentrations <
25–30 nmol/L) [18, 19]. A smaller systematic review and
meta-analysis assessing healthy young adults (18–40 y)
included six RCT’s and one controlled study assessing
upper and lower limb strength and vitamin D. The
authors conclude that vitamin D supplementation had a
significant positive effect on muscle strength, and also
that the lack of studies in the young adult population
calls for further studies [42].
A Danish study assessed the effects of high dose
(2500 μg/week for 1 month followed by 2500 μg/
month for 5 months) vitamin D supplementation in
women of Arabic origin (n = 55) with a Danish con-
trol group (n = 22). The women of Arabic origin had
a baseline serum 25(OH)D concentration of 6.7 (0.6)
nmol/L compared to the women of Danish origin
having a serum 25(OH)D concentration of 47.1 (4.6)
nmol/L. A very low baseline knee extension strength
(maximum voluntary) was found among the women
of Arabic origin of 26.4 kg, which was 34% lower than
the 32.7 kg among the women of Danish origin. After
high dose treatment, the ethnic difference disap-
peared. In addition, a significant reduction in reports
Table 4 Muscle strength and body composition at baseline, endpoint and the change following intervention1
Danish Pakistani
Placebo (n = 35) Fortified (n = 31) Placebo (n = 37) Fortified (n = 33) P2
Handgrip strength (kg)
Baseline 34.5 (4.2)de 33.2 (4.2)c 27.9 (6.6)ce 30.3 (6.2)d < 0.001
Endpoint 34.07 (3.8)de 33.3 (4.3)c 28.0 (6.1)ce 30.3 (5.5)d < 0.001
Change −0.46 (2.3) − 0.1 (3.0) 0.2 (3.0) 0.5 (3.5) 0.66
Knee extension strength (kg)
Baseline 34.0 (5.7)e 36.5 (5.9)bc 27.7 (6.5)ce 31.1 (7.7)b < 0.001
Endpoint 35.0 (5.9)e 37.5 (5.4)bc 27.5 (6.7)ce 31.2 (7.8)b < 0.001
Change 0.3 (4.5) 1.0 (3.9) −0.15 (5.0) 0.6 (4.3) 0.79
Chair-stand test (Mean rep/min)
Baseline 23.4 (5.9) 24.0 (5.0)c 19.9 (5.5)c 22.6 (7.1) 0.04
Endpoint 24.7 (6.6) 26.8 (6.5)c 21.9 (5.9)c 23.9 (7.2) 0.045
Change 1.2 (3.0) 2.7 (3.6) 1.3 (3.4) 1.6 (3.6) 0.35
Mean BMI (kg/m2)
Baseline 24.6 (5.1) 24.1 (4.0)bc 27.1 (24.8)c 27.4 (4.7)b 0.007
Endpoint 24.4 (4.3) 24.1 (3.9)bc 27.2 (5.1)c 27.2 (4.3)b 0.005
Change 0.1 (0.5) 0.2 (0.5) 0.2 (0.5) 0.1 (0.5) 0.97
Mean fat %
Baseline 32.6 (7.6)de 30.1 (7.3)bc 37.1 (6.1)ce 37.6 (5.7)bd < 0.001
Endpoint 32.0 (7.4)de 30.7 (7.1)bc 36.6 (6.4)ce 37.4 (5.6)bd < 0.001
Change −0.11 (1.9) 0.7 (2.3) −0.3 (1.4) 0.16 (1.7) 0.20
Mean lean mass (kg)
Baseline 46.5 (4.7)e 47.1 (3.0)bc 42.8 (4.7)ce 43.8 (4.7)b < 0.001
Endpoint 46.5 (4.3)de 46.8 (3.0)bc 43.2 (4.8)ce 43.16 (4.1)bd < 0.001
Change 0.22 (1.3) −0.05 (1.3) 0.43 (1.0) 0.06 (0.87) 0.37
1Means and SD unless otherwise specified.
2P values for comparisons over the four study group were determined with the use of a one-way ANOVA followed by Tukey’s test. Significant comparisons a: DK
Placebo vs DK Fortified, b: PA Fortified vs DK Fortified, c: PA Placebo vs DK Fortified, d: PA Fortified vs DK Placebo, e: PA Placebo vs DK Placebo, f: PA Placebo vs
PA Fortified.
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Table 5 The effect of intervention with vitamin D fortified foods on the markers of bone turnover OC, BALP, P1NP and CTX,
analysed in an ANCOVA including the baseline covariates that may influence the outcome (age, ethnicity, intervention group and
BMI)
Coefficients Estimate 95% CI P Estimate 95% CI P
Δ OC Model 1 (minimal) Model 2 (maximal)
Intercept1 3.14 (0.95; 5.32) 0.005 (**) 6.53 (1.69; 11.4) 0.01 (*)
Baseline OC −0.20 (− 0.27; − 0.12) < 0.0001 (***) − 0.21 (− 0.29; − 0.13) < 0.0001 (***)
Ethnicity:
Danish – – – – – –
Pakistani 0.50 (−0.87; 1.83) 0.50 −0.70 (− 0.67; 2.07) 0.31
Intervention group:
Fortified −0.57 (−1.87; 0.72) 0.39 −0.60 (−1.86; 0.66) 0.35
Placebo – – – – – –
BMI −0.10 (− 0.25; 0.05) 0.20
Age − 0.01 (−0.08; 0.06) 0.69
Δ BALP Model 1 (minimal) Model 2 (maximal)
Intercept1 3.4 (1.93; 4.94) < 0.0001 (***) 0.50 (−2.6; 3.59) 0.75
Baseline BALP −0.32 (−0.40; − 0.24) < 0.0001 (***) −0.25 (− 0.33; − 0.17) < 0.0001 (***)
Ethnicity:
Danish – – – – – –
Pakistani 0.2 (−0.84; 1.23) 0.71 0.07 (− 0.93; 1.08) 0.88
Intervention group:
Fortified −0.03 (−1.06; 1.00) 0.95 0.19 (−0.76; 1.13) 0.70
Placebo – – – – – –
BMI 0.05 (−0.07; 0.16) 0.43
Age 0.02 (−0.03; 0.07) 0.42
Δ P1NP Model 1 (minimal) Model 2 (maximal)
Intercept1 6.81 (1.78; 11.84) 0.005 (**) 13.4 (1.10; 25.8) 0.03 (*)
Baseline P1NP −0.17 (− 0.25; − 0.09) < 0.0001 (***) − 0.19 (− 0.28; − 0.11) < 0.0001 (***)
Ethnicity:
Danish – – – – – –
Pakistani 1.88 (−1.52; 5.28) 0.28 1.79 (−1.78; 5.35) 0.32
Intervention group:
Fortified −1.36 (−4.75; 2.04) 0.43 −1.63 (−5.02; 1.76) 0.34
Placebo – – – – – –
BMI 0.04 (−0.37; 0.45) 0.85
Age −0.18 (−0.36; 0.01) 0.07
Δ CTX Model 1 (minimal) Model 2 (maximal)
Intercept1 0.06 (0.03; 0.10) < 0.0001 (***) 7.2−2 (−0.03; 0.17) 0.15
Baseline CTX −0.33 (−0.42; − 0.23) < 0.0001 (***) −0.33 (− 0.43; − 0.23) < 0.0001 (***)
Ethnicity:
Danish – – – – – –
Pakistani −0.004 (−0.03; 0.02) 0.80 −0.003 (− 0.03; 0.03) 0.82
Intervention group:
Fortified −0.01 (−0.04; 0.02) 0.40 −0.01 (− 0.04; 0.01) 0.37
Placebo – – – – – –
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Table 5 The effect of intervention with vitamin D fortified foods on the markers of bone turnover OC, BALP, P1NP and CTX,
analysed in an ANCOVA including the baseline covariates that may influence the outcome (age, ethnicity, intervention group and
BMI) (Continued)
Coefficients Estimate 95% CI P Estimate 95% CI P
BMI −2.1−4 (−0.004; 0.003) 0.91
Age −2.8−6 (−0.002; 0.002) 1.00
1The reference group is included in the intercept: Danish ethnicity and placebo study group
Table 6 The change in muscle strength measured as handgrip strength and knee extension strength and a 30 s chair-standing test,
analysed in an ANCOVA including the baseline covariates that may influence the outcome (age, ethnicity, intervention group and
BMI)
Coefficients Estimate 95% CI P Estimate 95% CI P
Δ Handgrip strength Model 1 (minimal) Model 2 (maximal)
Intercept1 6.80 (3.56; 10.0) < 0.0001 (***) 6.56 (2.32; 10.8) < 0.003 (**)
Baseline handgrip strength −0.21 (−0.31; − 0.12) < 0.0001 (***) − 0.22 (− 0.31; − 0.12) < 0.0001 (***)
Ethnicity:
Danish – – – – – –
Pakistani − 0.53 (−1.63; 0.58) 0.35 − 0.63 (−1.82; 0.56) 0.30
Intervention group:
Fortified 0.38 (−0.62; 1.37) 0.46 0.48 (−0.54; 1.50) 0.35
Placebo – – – – – –
BMI 0.01 (−0.11; 0.13) 0.88
Age −0.003 (−0.05; 0.06) 0.99
Δ Knee extension strength Model 1 (minimal) Model 2 (maximal)
Intercept1 8.66 (4.16; 13.16) < 0.0001 (***) 9.93 (3.82; 16.21) < 0.0001 (***)
Baseline knee extension strength −0.24 (−0.37; − 0.12) < 0.0001 (***) − 0.25 (− 0.38; − 0.12) < 0.0001 (***)
Ethnicity:
Danish – – – – – –
Pakistani −1.96 (−3.69; − 0.23) 0.03 (*) −1.95 (−4.24; 0.54) 0.03 (*)
Intervention group:
Fortified 1.23 (−0.34; 2.81) 0.12 1.21 (−0.94; 3.52) 0.13
Placebo – – – – – –
BMI −0.02 (−0.20; 0.18) 0.87
Age −0.03 (−0.11; 0.06) 0.46
Δ Chair-standing test Model 1 (minimal) Model 2 (maximal)
Intercept1 2.54 (−0.22; 5.31) 0.07 5.90 (0.78; 11.0) 0.02 (*)
Baseline chair-standing −0.05 (− 0.15; 0.06) 0.41 − 0.06 (− 0.17; 0.06) 0.30
Ethnicity:
Danish – – – – – –
Pakistani −0.56 (−1.86; 0.74) 0.39 −0.01 (−1.45; 1.24) 0.88
Intervention group:
Fortified 0.94 (−0.34; 2.22) 0.15 0.93 (−0.34; 2.20) 0.15
Placebo – – – – – –
BMI −0.16 (−0.31; − 0.004) 0.04 (*)
Age 0.02 (−0.05; 0.09) 0.56
1The reference group is included in the intercept: Danish ethnicity and placebo study group
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of muscle and bone pain among the women of Arabic
origin [43].
In the present study the serum 25(OH)D concentra-
tion in the placebo groups decreased by 2.8 (9) nmol/L
in the Danish placebo group and by 11.2 (12) nmol/L in
the Pakistani placebo group, however we did not see a
significant decrease in muscle strength and bone forma-
tion markers or increase of the bone resorption marker
(CTX) following the intervention. Based on the above,
the present study suggests that a vitamin D status of ≈
50 nmol/L measured at winter time (start of January)
would be sufficient to maintain healthy muscle and bone
during the following winter months.
Strengths and limitations
The ODIN FOOD study was carried out in winter which
is a strength in relation to avoiding confounding from
vitamin D originating from UVB sources as no cutane-
ous production of vitamin D occurs during the months
of winter (October–April) at Danish latitudes [10, 44].
An additional strength was the real-life setting of the
study and thereby the applicability of the results in a
public health setting. A limitation affecting health and
nutrition studies in general is the bias of social selection
during recruitment, this may also be a factor in this
study. The fact that the participants may be a selected
group, must be taken into account when interpreting the
results.
The study was designed to detect the effect of vitamin
D fortification on serum 25(OH)D concentration and
thus, the power calculation was made with vitamin D
status as the response variable. This may affect the re-
sults of secondary endpoint analyses such as muscle
strength and bone markers due to a too low power to
detect relevant changes in the mentioned endpoints.
Several limitations are present when using markers of
bone remodelling. Large pre-analytical and analytical
variability are seen and markers of bone turnover are af-
fected by modifiable factors such as circadian rhythm,
season, ethnicity, fasting state, physical activity and men-
strual cycle [14]. Additionally, there are no standardised
assays for bone markers. Since we were not able to ob-
tain fasting blood samples from the participants due to
logistical reasons, we attempted to book the participant
at the same hour of the day at the two different mea-
surements in order to minimise the preanalytical
variability.
With regard to the study duration, 12 weeks has been
shown to be the minimum time used in previous studies
and may in fact have been too short a period to detect
any changes in muscle strength and bone markers [19,
26] especially if the participants are in a vitamin D re-
plete state of vitamin D, little may change following an
intervention with vitamin D [19].
At baseline, the participants would perform the muscle
test for the first time, whereas at the endpoint measure-
ment there may be some familiarity of the muscle tests.
Despite performing familiarisation trials before the tests,
and giving the participants up to two additional muscle
tests trials if the last one were the highest we cannot rule
out that this may influence the score because of inex-
perience and reluctance to exert full capacity of power at
baseline, compared to the endpoint.
Although successfully developed for older adults [29],
the 30 s chair-stand test has also been used on people
within our target group [45]. However, this test may not
be completely optimal for this target group because the
participants may have memorised their own baseline test
results and some may even have tried to improve their
score at the endpoint test. Also, participants with good
physical fitness performed the test so fast that some had
problems with the balance as a result of this.
Conclusion
Consumption of vitamin D fortified foods for 12 weeks
did not result in significant changes of the bone turnover
markers OC, BALP, P1NP and CTX. Muscle strength
measured as hand grip strength, knee extension strength
and chair-standing did not change significantly following
the intervention.
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